Ministry of Health, Labour and Welfare Prevention of Kidney Disease Progression Action Plan

Similar documents
Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

DIABETES AND LABORATORY TESTS. Author: Josephine Davis

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

Personal Diabetes Passport

Diabetes and Hypertension

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153

The future is here. It s just not widely distributed yet. William Gibson

Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases

Fullerton Healthcare Screening Centres

Management of early chronic kidney disease

The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan

Kana Kazawa Yae Takeshita Noriaki Yorioka Michiko Moriyama

Clinical Study Factors Associated with the Decline of Kidney Function Differ among egfr Strata in Subjects with Type 2 Diabetes Mellitus

Epidemiologic Survey of Radiation Health Effects - Survey of Health Effects of Atomic Bomb Radiation -

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

Your health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Supplementary Appendix

Cardiac Pathophysiology

Nutrition Care Process. Catherine Villafranca & Anthony Richitt

Protocol GTC : A Randomized, Open Label, Parallel Design Study of Sevelamer Hydrochloride (Renagel ) in Chronic Kidney Disease Patients.

Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea

Tests by age. specific inherited syndromes and inflammatory bowel disease

Professor Suetonia Palmer

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

Case study for CME Diabetes up-to-date management

Hop on The Right Track

Chemistry Reference Ranges and Critical Values

Chemistry Reference Ranges and Critical Values

Supplementary Table 1. Criteria for selection of normal control individuals among healthy volunteers

2013 Hypertension Measure Group Patient Visit Form

Client Report Screening Program Results For: Missouri Western State University October 28, 2013

The volunteers were divided into three parts to study the effect of BESEB.

National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register

ANNUAL HEALTH CHECKUP BASIC HEALTH PACKAGE

TEST LIST SAMPLE REQUIREMENT. 1 ml serum None

Waist Circumference Measurements in Special Metabolic Syndrome Medical Checkups for Employees of a Japanese University: A Follow-up Study

Applying clinical guidelines treating and managing CKD

ORIGINAL ARTICLE. Abstract. Introduction

Supplementary Online Content

ORIGINAL ARTICLE. Abstract. Introduction. Minako Wakasugi 1, Junichiro James Kazama 2 and Ichiei Narita 2

Diabetic Nephropathy. Objectives:

Renal Protection Staying on Target

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

Get to know yourself better. Attend our health screening event.

Application of the Diabetes Algorithm to a Patient

ENROLLMENT CONFIRMATION

CONCORD INTERNAL MEDICINE CHRONIC KIDNEY DISEASE PROTOCOL. Revised May 30, 2012

CLINICAL GUIDELINE. Document No:CG38 *All Sites Management of adult patients referred to South Tees University Hospitals for hypertension.

Diabetes Overview. How Food is Digested

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.

Patient enrolment details CKDOD registry

Metabolic Syndrome and Chronic Kidney Disease

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019

Recent Change in the Annual Incidence of Childhood Type 2 Diabetes in the Tokyo Metropolitan Area

PLEASE REMEMBER TO BRING TO EACH APPOINTMENT

AGING KIDNEY IN HIV DISEASE

PanDA Pancreatic cancer Dietary Assessment study

Maryland-National Capital Park Police Prince George s County Division DIVISION DIRECTIVE DISTRIBUTION

Diabetic Nephropathy

Director, Employee Health & Productivity. Coordinator, Employee Health & Productivity

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah

Rapid Laboratories In House Tests

Key Elements in Managing Diabetes

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Positive Change for Life

Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management

QUALITY HEALTHCARE MEN'S PHYSICAL CHECK-UP ELIGIBLE TO EARN ASIA MILES

Get to know yourself better. Attend our health screening event.

HIV AND CHRONIC KIDNEY DISEASE. Understanding GFR

Specific Panels. Celiac disease panel. Pancreas Panel:

CVD Prevention, Who to Consider

360 Health Assessment.

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

Long-Term Care Updates

Choosing Wisely Long Term Care Uniquely Canadian

year resident, Department of Medicine, B. J. Medical college, Ahmedabad.

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

This information is intended to be used with the help of a relevant health professional, and is available as a booklet to download.

Association of urine acidification with visceral obesity and the metabolic syndrome

Individual Study Table Referring to Part of Dossier: Volume: Page:

Count y of Dupage. The Empower Wellness Screening Program. Thoughtfully designed to help you take control of your health

Health Survey for England: health, social care and lifestyles

A practical approach of salt and protein restriction for CKD patients in Japan

Urban Diabetes Care and Outcomes Audit Report: Aggregate Results from Urban Indian Health Organizations, May 2012

Introduction to Clinical Diagnosis Nephrology

Case Study: Chronic Kidney Disease

BASELINE CHARACTERISTICS OF THE STUDY POPULATION

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

M Series. Health Screening Just Got A Whole Lot Easier EARLY DETECTION BETTER MANAGEMENT IMPROVED OUTCOMES

Multiphasic Blood Analysis

ADPedKD: detailed description of data which will be collected in this registry

HEALTH CHECK PACKAGES. An ounce of prevention is better than a pound of care. Benjamin Franklin

N A B H. * Our whitefield branch is NABH accredited. Health RxDx.

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

Routine Clinic Lab Studies

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

DIABETES AND YOUR KIDNEYS

Transcription:

9 th IKEAJ-CKD International Symposium Ministry of Health, Labour and Welfare Prevention of Kidney Disease Progression Action Plan Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon University School of Medicine Kazuyoshi Okada

Background A large-scale outcome study was conducted over five years from 2007 until 2011 by the strategic research team for the Prevention of Kidney Disease Progression, part of the Health and Labour Sciences Research group, in an attempt to confront this national problem. Following a strict study protocol, this led to the creation of a Lifestyle and Diet handbook aimed at providing guidance to patients with chronic kidney disease (CKD). In order to optimize the handbook by taking regional characteristics into consideration, allowing immediate implementation in each designated region, modifications were required. Accordingly, the Ministry of Health, Labour and Welfare conducted an open recruitment for the implementation of the Prevention of Kidney Disease Progression Action Plan. The IKEAJ was selected to implement the project in the Hokkaido, Tohoku and Kanto regions.

Study Objectives To make necessary modifications to the Lifestyle and Diet handbook prepared by the strategic research team for the Prevention of Kidney Disease Progression, thereby creating an optimum handbook which takes regional characteristics into consideration, allowing immediate implementation in each designated region. To use the handbook to provide individual guidance on lifestyle and diet to patients with CKD, and, subsequently, evaluate the effectiveness of the methods outlined in the handbook.

Study Design Open-label Study Subjects Inclusion criteria 1. Aged 20 years or above. 2. CKD stage 1 to 4. 3. Subjects who take blood pressure measurements at home (morning and before bed) using an upper arm monitor. 4. Willing to consent to undergo tests (urine and blood), receive guidance (lifestyle and diet) and fill out medical questionnaires every 3 months. 5. Willing to provide written consent. Exclusion criteria 1. Those who fail to strictly comply with the guidance given.

Procedure 1. 2. 3. On admission, all subjects are required to complete the medical questionnaire and sign the informed consent form. Height, weight, waist circumference and blood pressure measurements will then be recorded, average home blood pressure values calculated and the official section of the medical questionnaire completed. The informed consent form, medical questionnaire and list of medications will then be submitted to IKEAJ. Once notified of the registration number by IKEAJ, the study will be started and blood tests and urinalysis performed. A 3-month observation period will be established. Three months after the initial examination (urine and blood), a second examination will be performed and guidance given on lifestyle and diet. Further examinations and additional guidance on lifestyle and diet will subsequently be performed at 3-month intervals thereafter. Medical questionnaires completed at the second and subsequent examinations will be submitted to IKEAJ.

Testing program All laboratory tests were performed with samples collected during the medical examination and sent on the same day to a central laboratory vendor (SRL, Inc., Tokyo, Japan). 1 2 3 Measurement of blood pressure, height, weight and waist circumference Urine protein (qualitative), urinary glucose (qualitative), urinary occult blood reaction, urinary albumin excretion rate (quantitative), urinary protein (quantitative), urinary creatinine, urinary Na, urinary K Hemoglobin, Fe, TIBC, ferritin, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, glucose, HbA1c, albumin, K, urea nitrogen, creatinine, egfr (Cr; ml/min/1.73 m 2 ), uric acid, cystatin C, egfr (Cys-C; ml/min/1.73 m 2 )

Lifestyle guidance Lifestyle guidance will be provided by physicians or dietitians, who will also, on a regular basis, confirm that the subjects are complying with the guidance given, before continuing with instruction Dietary guidance Dietary guidance will be provided by dietitians of the same person in principle who will also, on a regular basis, confirm that the subjects are complying with the guidance given, before continuing with instruction

Documents 1 2 3 Program for the Prevention of Kidney Disease Progression First Examination Follow-up Examination Food record chart Diet and Exercise Check Sheet

Program for the Prevention of Kidney Disease Progression (First Examination)

Program for the Prevention of Kidney Disease Progression (Follow-up Examination)

Food record chart

Diet and Exercise Check Sheet

Study Period From November 29, 2012 until completion of the Prevention of Kidney Disease Progression Action Plan. Registration Period From November 29, 2012 to December 31, 2013 Target Number of Subjects 150 subjects

Endpoints Primary Endpoints 1. Changes in egfr (Cr) 2. Changes in egfr (Cystatin C) 3. Changes in urinary albumin excretion 4. Changes in quantitative urine protein Secondary Endpoints 1. Changes in abdominal circumference and body mass index 2. Changes in average home blood pressure values (morning, before bed) 3. Changes in the central measurement test values (BS, HbA1c, LDL-C, HDL-C, TG, non HDL-CUA, Hb, Alb, Fe, TIBC, ferritin, Cr, cystatin C, urinary Na) 4. Evaluation of changes in parameters due to compliance with lifestyle guidance. 5. Evaluation of changes in parameters due to compliance with dietary guidance.

Follow-up 2013. 1.31 observation period 3 months Study period number of registration number of dropout number of the first examination number of the second examination number of the third examination number of the forth examination 169 8 161 126 60 0